The Crosetto Foundation for the Reduction of Cancer Deaths has issued a compelling call to Members of the European Parliament (MEPs) to intervene in the allocation of CERN's funding. At the heart of this appeal is the groundbreaking 3D-Flow technology invented by Italian-American scientist Dario Crosetto in 1992. Recognized for its unparalleled efficiency in processing ultra-high-data streams, this technology promises not only to revolutionize particle physics research at CERN but also to pave the way for early cancer detection through the 3D-Complete Body Screening (3D-CBS) system.
Despite its proven superiority and the potential to save billions in taxpayer funds, CERN has persisted with the Field Programmable Gate Array (FPGA) architecture, a decision that has led to significant financial waste and delayed the realization of life-saving medical technologies. The Crosetto Foundation's plea underscores a critical juncture in scientific research funding, where the choice between outdated technologies and innovative solutions could have far-reaching implications for both the scientific community and public health.
The foundation's call to action is not merely about correcting past financial misallocations but about ensuring a future where scientific advancements are both cost-effective and life-saving. The 3D-Flow technology, with its ability to perform over 8,000 programmable operations at a fraction of the cost and energy consumption of current systems, represents a beacon of hope for accelerating research in particle physics and oncology. The urgency of this matter cannot be overstated, as the continued reliance on inefficient technologies at CERN not only squanders public funds but also postpones the advent of technologies capable of detecting cancer at its earliest, most treatable stages.
This situation presents a unique opportunity for MEPs to exercise their oversight authority, ensuring that taxpayer money is directed towards technologies that offer the greatest benefit to society. The Crosetto Foundation's appeal is a reminder of the moral and financial responsibilities that come with public funding of scientific research. It is a call to prioritize transparency, accountability, and, above all, the potential to save lives through innovation.
